Intensity-modulated Radiation Therapy for Anal Cancer

UKCCCR Anal Cancer Trial Working, 1996, UK Co-ordinating Committee on Cancer Research. Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin., Lancet, 348, 1049, 10.1016/S0140-6736(96)03409-5

Ajani, 2008, . Fluorouracil, mitomycin, and radiotherapy vs. fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial., JAMA, 299, 1914, 10.1001/jama.299.16.1914

Bartelink, 1997, . Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups., J Clin Oncol, 15, 2040, 10.1200/JCO.1997.15.5.2040

Flam, 1996, . Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study., J Clin Oncol, 14, 2527, 10.1200/JCO.1996.14.9.2527

Kachnic, 2009, . Radiation Therapy Oncology Group. A phase II evaluation of dose-painted IMRT in combination with 5-fluorouracil and mitomycin-C for reduction of acute morbidity in carcinoma of the anal canal., Int J Radiat Oncol Biol Phys, 75, S5, 10.1016/j.ijrobp.2009.07.038

Kachnic, 2010, . Early efficacy results of RTOG 0529: a phase II evaluation of dose-painted IMRT in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal., Int J Radiat Oncol Biol Phys, 78, S55, 10.1016/j.ijrobp.2010.07.162

Kachnic, 2012, . Dose-painted intensity-modulated radiation therapy for anal cancer: a multi-institutional report of acute toxicity and response to therapy., Int J Radiat Oncol Biol Phys, 82, 153, 10.1016/j.ijrobp.2010.09.030

Milano, 2005, . Intensity-modulated radiation therapy (IMRT) in the treatment of anal cancer: toxicity and clinical outcome., Int J Radiat Oncol Biol Phys, 63, 354, 10.1016/j.ijrobp.2005.02.030

Pepek, 2010, . Intensity-modulate radiation therapy for anal malignancies: a preliminary toxicity and disease outcomes analysis., Int J Radiat Oncol Biol Phys, 78, 1413, 10.1016/j.ijrobp.2009.09.046

Salama, 2007, . Concurrent chemotherapy and intensity-modulated radiation therapy for anal canal cancer patients: a multicenter experience., J Clin Oncol, 25, 4581, 10.1200/JCO.2007.12.0170

Call, 2013, . Concurrent chemotherapy and intensity modulated radiation therapy in the treatment of anal cancer: a retrospective review from a large academic center., Pract Radiat Oncol, 3, 26, 10.1016/j.prro.2012.02.005

Bazan, 2011, . Intensity-modulated radiation therapy versus conventional radiation therapy for squamous cell carcinoma of the anal canal., Cancer, 117, 3342, 10.1002/cncr.25901

James, 2009, . A randomized trial of chemoradiation using mitomycin or cisplatin, with or without maintenance cisplatin5FU in squamous cell carcinoma of the anus (ACT II)., J Clin Oncol, 27, 2, 10.1200/jco.2009.27.15_suppl.lba4009

Mell, 2006, . Dosimetric predictors of acute hematologic toxicity in anal cancer patients treated with concurrent chemotherapy and intensity modulated radiation therapy (IMRT)., Int J Radiat Oncol Biol Phys, 66, S277, 10.1016/j.ijrobp.2006.07.525

Mell, 2008, . Association between bone marrow dosimetric parameters and acute hematologic toxicity in anal cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy., Int J Radiat Oncol Biol Phys, 70, 1431, 10.1016/j.ijrobp.2007.08.074

Brixey, 2002, . Impact of intensity-modulated radiotherapy on acute hematologic toxicity in women with gynecologic malignancies., Int J Radiat Oncol Biol Phys, 54, 1388, 10.1016/S0360-3016(02)03801-4